OLD Category: panels

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)

• Bian B et al.,

BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy

• Kim SB et al.,

Should a Multigene Signature be Used in all Luminal Early Breast Cancers

• Hajjaji N et al.,

Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial

• Gluz O et al.,

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

• Picornell AC et al.,

Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism

• Götzl JK et al.,

An immunome perturbation is present in juvenile idiopathic arthritis patients who are in remission and will relapse upon anti-TNFα withdrawal

• Leong JY et al.,

Temporal Profile of Transporter mRNA Expression in the Brain after Traumatic Brain Injury in Developing Rats

• Adams SM et al.,

Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans

• Jamshed H et al.,

Molecular classification of epithelial ovarian cancer based on methylation profiling: evidence for survival heterogeneity

• Bodelon C et al.,

Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn’s Disease and Ulcerative Colitis Patients

• Bsat M et al.,

Selenium Deficiency Is Associated with Pro-longevity Mechanisms

• Yim SH et al.,